Cancer diagnostics often begin with a biopsy and histopathologic examination, from the basis of physical examination and medical history. Sometimes the first indication is an abnormal laboratory test result (eg, anemia resulting from colon cancer). 
            
            
            
         
     
    
        
                    
                                    
                
         
                
                    
                                        
                        
                    
                            - 
                    
                                                                    
                                    
                                        
    
    
    
        Laboratory implementation of clinical genomics in children requires customization of analytical tools tailored to profile the divergent mutational landscape in childhood tumors. The relative...
     
 
 
                                    
                                                                    
                                    
                                        
    
            
    
    
    
        Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    
    
            
     
                                     
                                    
                                                                    
                                    
                                        
    
            
    
    
    
        Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
    
    
            
     
                                     
                                    
                                                                    
                                    
                                        
    
    
    
        According to the American Cancer Society, in there were an estimated 110,070 new cases diagnosed and approximately 32,120 deaths from gynecologic cancers in the U.S. in 2018. Of the five mos...
    
    
            
     
                                     
                                    
                                                                    
                                    
                                        
    
    
    
        As the SARS-CoV-2 continues to spread and evolve and vaccination efforts are under way, countries around the world are confronting new public health challenges due to the emergence and rapid...
    
    
            
     
                                     
                                    
                                                                    
                                    
                                        
    
    
    
        Over a year into the COVID-19 pandemic, key vulnerable populations in the United States and across the world lack access to effective vaccines. IDRI has developed technology that addresses s...
    
    
            
     
                                     
                                    
                                                                    
                                    
                                        
    
    
    
        One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to earl...